GSA Capital Partners’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-47,416
| Closed | -$233K | – | 2207 |
|
|
2016
Q4 | $233K | Buy |
+47,416
| New | +$233K | 0.01% | 1499 |
|
|
2016
Q2 | – | Sell |
-72,601
| Closed | -$415K | – | 2080 |
|
|
2016
Q1 | $415K | Sell |
72,601
-26,300
| -27% | -$150K | 0.03% | 1127 |
|
|
2015
Q4 | $1.03M | Buy |
98,901
+9,702
| +11% | +$101K | 0.05% | 688 |
|
|
2015
Q3 | $1.65M | Buy |
89,199
+18,031
| +25% | +$333K | 0.08% | 358 |
|
|
2015
Q2 | $1.39M | Buy |
71,168
+24,141
| +51% | +$470K | 0.05% | 633 |
|
|
2015
Q1 | $827K | Buy |
+47,027
| New | +$827K | 0.03% | 1022 |
|
|
2014
Q3 | – | Sell |
-16,977
| Closed | -$265K | – | 2157 |
|
|
2014
Q2 | $265K | Buy |
+16,977
| New | +$265K | 0.01% | 1481 |
|
|
2013
Q3 | – | Sell |
-21,457
| Closed | -$216K | – | 1780 |
|
|
2013
Q2 | $216K | Buy |
+21,457
| New | +$216K | 0.03% | 1046 |
|